Overview

A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, dose-escalating, placebo-controlled phase Ib clinical study.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu vcare pharmaceutical technology co., LTD